help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Offner, F. A.
Right arrow Articles by Knabbe, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Offner, F. A.
Right arrow Articles by Knabbe, C.

American Journal of Pathology, Vol 148, 1679-1688, Copyright © 1996 by American Society for Investigative Pathology


REGULAR ARTICLES

Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1

FA Offner, H Feichtinger, S Stadlmann, P Obrist, C Marth, P Klingler, B Grage, M Schmahl and C Knabbe
Department of Pathology, University of Innsbruck, Austria.

Peritoneal mesothelial cells are uniquely located to regulate cellular events in the peritoneal cavity and are a potentially important source for various cytokines. The present study was designed to elucidate the capacity of human peritoneal mesothelial cells (HPMCs) to synthesize and secrete the transforming growth factor (TGF)-beta isoforms 1, 2, and 3 and to characterize their regulation by inflammatory cytokines. HPMCs constitutively released appreciable amounts of TGF-beta 1 and low amounts of TGF-beta 2 as detected by specific immunoassays. TGF-beta 1 levels secreted within 48 hours (45 +/- 8.9 pg/10(5) cells) were 60- fold higher than TGF-beta 2 levels (0.9 +/- 0.1 pg/10(5) cells), respectively. Treatment of HPMCs with interleukin (IL)-1 beta (10 ng/ml) resulted in a significant increase of both TGF-beta 1 (mean, 5- fold; P < 0.001) and TGF-beta 2 (mean, 6-fold; P < 0.01) generation. After 48 hours of IL-1 beta treatment the levels were 185 +/- 17.1 pg/10(5) cells for TGF-beta 1 and 5.3 +/- 1.5 pg/10(5) cells for TGF- beta 2, respectively. Neither tumor necrosis factor (TNF)-alpha nor interferon (IFN)-gamma (both 10 ng/ml) affected TGF-beta 1 or TGF-beta 2 synthesis by HPMCs. TGF-beta 3 could not be detected in any of the supernatant media. Stimulation of HPMCs with IL-1 beta increased steady- state levels of TGF-beta 1- and TGF-beta 2-specific mRNA. Western blot analysis of supernatants revealed the presence of an immunoreactive band at 25 kd. Indirect competition assays confirmed receptor-binding activity of HPMC-derived TGF-beta. Appreciable amounts of TGF-beta were present in a bioactive form. Our results demonstrate that HPMCs synthesize the TGF-beta isoforms 1 and 2 and that the levels of mRNA and protein release can be up-regulated by the proinflammatory cytokine IL-1 beta.


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
C.-C. Fang, C.-J. Yen, Y.-M. Chen, T.-S. Chu, M.-T. Lin, J.-Y. Yang, and T.-J. Tsai
Diltiazem suppresses collagen synthesis and IL-1{beta}-induced TGF-{beta}1 production on human peritoneal mesothelial cells
Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1340 - 1347.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K.-Y. Lee, K. Ito, R. Hayashi, E. P. I. Jazrawi, P. J. Barnes, and I. M. Adcock
NF-{kappa}B and Activator Protein 1 Response Elements and the Role of Histone Modifications in IL-1{beta}-Induced TGF-{beta}1 Gene Transcription
J. Immunol., January 1, 2006; 176(1): 603 - 615.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C.-L. Chung, C.-H. Chen, J.-R. Sheu, Y.-C. Chen, and S.-C. Chang
Proinflammatory Cytokines, Transforming Growth Factor-{beta}1, and Fibrinolytic Enzymes in Loculated and Free-Flowing Pleural Exudates
Chest, August 1, 2005; 128(2): 690 - 697.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Yung, X.-R. Chen, R. C. Tsang, Q. Zhang, and T. M. Chan
Reduction of Perlecan Synthesis and Induction of TGF-{beta}1 in Human Peritoneal Mesothelial Cells Due to High Dialysate Glucose Concentration: Implication in Peritoneal Dialysis
J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1178 - 1188.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Y.C. Cheong, S.M. Laird, J.B. Shelton, W.L. Ledger, T.C. Li, and I.D. Cooke
The correlation of adhesions and peritoneal fluid cytokine concentrations: a pilot study
Hum. Reprod., April 1, 2002; 17(4): 1039 - 1045.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Chamberlain, J. Gunn, S. E. Francis, C. M. Holt, N. D. Arnold, D. C. Cumberland, M. W.J. Ferguson, and D. C. Crossman
TGF{beta} is active, and correlates with activators of TGF{beta}, following porcine coronary angioplasty
Cardiovasc Res, April 1, 2001; 50(1): 125 - 136.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
M. M. P. J. Reijnen, H. van Goor, P. Falk, M. Hedgren, and L. Holmdahl
Sodium Hyaluronate Increases the Fibrinolytic Response of Human Peritoneal Mesothelial Cells Exposed to Tumor Necrosis Factor {alpha}
Arch Surg, March 1, 2001; 136(3): 291 - 296.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. ITO, N. YORIOKA, M. YAMAMOTO, K. KATAOKA, and M. YAMAKIDO
Effect of Glucose on Intercellular Junctions of Cultured Human Peritoneal Mesothelial Cells
J. Am. Soc. Nephrol., November 1, 2000; 11(11): 1969 - 1979.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
J. Chamberlain, J. Gunn, S. Francis, C. Holt, and D. Crossman
Temporal and spatial distribution of interleukin-1{beta} in balloon injured porcine coronary arteries
Cardiovasc Res, October 1, 1999; 44(1): 156 - 165.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. E. Francis, N. J. Camp, R. M. Dewberry, J. Gunn, P. Syrris, N. D. Carter, S. Jeffery, J. C. Kaski, D. C. Cumberland, G. W. Duff, et al.
Interleukin-1 Receptor Antagonist Gene Polymorphism and Coronary Artery Disease
Circulation, February 23, 1999; 99(7): 861 - 866.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.